Spruce Biosciences, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+17.3% +$8M
$53M
Current Assets↑+17.9% +$8M
$52M
Cash & Equivalents↑+26.2% +$10M
$49M
ST Investments
—
Receivables
—
Net PPE
—
Total Liabilities↓-35.9% -$6M
$11M
Current Liabilities↓-33.8% -$5M
$10M
Account Payables↓-27.2% -$352K
$943K
Long-Term Debt↓-100.0% -$124K
$0
Stockholders Equity↑+47.5% +$14M
$43M
Retained Earnings↓-15.6% -$39M
$-289M
Operating Lease ROU Asset
—
Operating Lease Liability↑+0.0% +$0
$736K
Accumulated Depreciation
—
Debt Due Y1↓-75.8% -$1M
$413K
Debt Due Y2↑+0.0% +$0
$136K
Debt Due Y3
$136K
Debt Due Y4
—
Debt Due Y5
—
Total Debt Carrying Amount↓-74.6% -$2M
$549K